Unlock instant, AI-driven research and patent intelligence for your innovation.

Mangiferin crystal V type substance and its preparation method as well as its composition and use

A composition, the technology of mangiferin, applied in the directions of drug combination, organic chemical method, pharmaceutical formula, etc., can solve the problem of no patent or literature report of mangiferin crystal form, and achieve the effect of good biological absorption advantage and fast absorption speed.

Active Publication Date: 2021-07-06
INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
View PDF15 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] After domestic and foreign patent and literature searches, no other crystal form patents or literature reports related to mangiferin were found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mangiferin crystal V type substance and its preparation method as well as its composition and use
  • Mangiferin crystal V type substance and its preparation method as well as its composition and use
  • Mangiferin crystal V type substance and its preparation method as well as its composition and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Preparation method 1 of mangiferin crystal type V sample:

[0067] Use ethanol: water (1:1) solvent to completely dissolve the mangiferin sample at 50°C, and quickly remove the solvent or prepare a solid mangiferin sample by cold / hot spraying under vacuum conditions at a temperature of 60°C. Carry out powder X-ray diffraction analysis to it, its diffraction pattern and image 3 Consistent, indicating that the obtained sample is mangiferin crystal type V solid matter.

[0068] Preparation method 2 of mangiferin crystal type V sample:

[0069] Use methanol: water (1:2) solvent to completely dissolve the mangiferin sample at 30°C, and quickly remove the solvent or prepare a solid mangiferin sample by cold / hot spraying under vacuum at a temperature of 50°C. Carry out powder X-ray diffraction analysis to it, its diffraction pattern and image 3 Consistent, indicating that the obtained sample is mangiferin crystal type V solid matter.

[0070] Preparation method 3 of mang...

Embodiment 2

[0087] Stability characteristics of mangiferin crystal type V solid matter:

[0088] High temperature test: put the crystal form sample in an open clean watch glass, place it at 60°C for 10 days, and take samples on the 0th day, the 5th day and the 10th day. Powder X-ray diffraction analysis is carried out to the sample obtained by the above-mentioned sampling points, and its diffraction patterns are all consistent with image 3 Consistent, indicating that the mangiferin crystal type V solid substance is stable under the high temperature influence factor test.

[0089] Illumination test: The crystal sample is placed in an open clean watch glass, placed in a light box equipped with a fluorescent lamp, and placed under the condition of an illumination of 4500lx±500lx for 10 days, and samples are taken on the 0th day, the 5th day and the 10th day. Powder X-ray diffraction analysis is carried out to the sample obtained by the above-mentioned sampling points, and its diffraction p...

Embodiment 3

[0093] Solubility characteristics of mangiferin crystal type Ⅰ and crystal Ⅴ solid substances in four solvent systems:

[0094] Selection of solvent system: ①Refer to the solvent system used in the dissolution method in the appendix of the Pharmacopoeia; ②Refer to the pH value of the digestive juice of different organs in the organism; ③Improve the solubility of poorly water-soluble drugs. According to the above 3 references, solvent systems with 4 pH values ​​were set up: 0.1N hydrochloric acid solution with a pH value of 1.2; acetate buffer solution with a pH value of 4.5; phosphate buffer solution with a pH value of 6.5; 6.7 in aqueous solution.

[0095] Refer to the solubility determination method ("Technical Guidelines for Dissolution Test of Ordinary Oral Solid Preparations (Draft)", 2012.10 Drug Evaluation Center) for determination. Adopt high-performance liquid chromatography to measure the mass percentage of sample dissolution to calculate the peak area, take time as...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the crystal type V of mangiferin compound (chemical name: 2-C-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone, English name: mangiferin) and its preparation method and its composition and use. Specifically, the present invention discloses that mangiferin exists in the form of crystal V solid material in a solid state; a method for preparing a sample of crystal V solid material; using mangiferin crystal V material as an active ingredient in the preparation of various liver The application of choleretic, cough and expectorant, anti-cancer, anti-hyperuricemia, drugs for the prevention and treatment of gout, diabetes and its metabolic diseases, and central nervous system diseases.

Description

technical field [0001] The present invention relates to the discovery of a crystal V solid state form in which mangiferin exists in a solid state; it relates to the invention of a preparation method for crystal V; The pharmaceutical composition of the mixed crystal form; the present invention also relates to the mangiferin crystal form substance as the active ingredient of the medicine, which can be used in the preparation of various hepatoprotective and choleretic, cough and expectorant, anti-cancer, anti-hyperuricemia, prevention and / or Application in drugs for the treatment of gout, diabetes and its metabolic diseases, and central nervous system diseases. Background technique [0002] Mangiferin compound (also known as mangiferin, Zhimuning. Chemical name: 2-C-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone, English name: mangiferin) molecular structure formula as follows: [0003] [0004] From the literature search, an article on ""Isolation and Crystal Structur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D407/04A61K31/352A61P1/16A61P11/10A61P11/14A61P19/06A61P35/00A61P3/10A61P3/00A61P25/00
CPCC07B2200/13C07D407/04
Inventor 吕扬杜冠华周琪杨世颖张丽赵赢周启蒙杨海光
Owner INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI